Nystatin oral is a topical antifungal medication used primarily to treat candidiasis (yeast infections) in the mouth, throat, and gastrointestinal tract. It comes most commonly as a liquid suspension that you swish around your mouth and then swallow, though lozenges and pastille forms also exist. Because nystatin is barely absorbed into the bloodstream, it fights fungal infections right where it makes contact, which makes it remarkably safe but also means technique matters more than you might expect.
What Nystatin Oral Treats
The most familiar use for oral nystatin is oropharyngeal candidiasis, better known as thrush. Thrush shows up as white or cream-colored patches on the tongue, inner cheeks, roof of the mouth, and sometimes the gums or tonsils. It can affect anyone, but it is especially common in infants, older adults who wear dentures, people taking inhaled corticosteroids for asthma, and those with weakened immune systems.
Beyond the mouth, nystatin suspension travels through the digestive tract and can address Candida overgrowth further down. It is one of the most frequently used non-absorbable antifungals for candidiasis of the orogastrointestinal tract and is an established part of Candida infection prevention in critically ill patients and premature infants.1PubMed Central. Yeasts in the Gut: From Commensals to Infectious Agents Because it stays in the gut rather than entering the bloodstream, its side-effect profile is mild compared to systemic antifungals.
How It Works and Why Contact Time Matters
Nystatin belongs to a class of antifungals called polyenes. It binds to a component in fungal cell membranes called ergosterol, punching holes in the membrane and causing the cell contents to leak out. Human cell membranes use cholesterol instead of ergosterol, which is why nystatin damages yeast cells while leaving your own tissue alone.
The critical thing to understand about oral nystatin is that it only works where it physically touches the fungus. Unlike fluconazole, which you swallow as a pill and which circulates through your blood to reach infected tissue from the inside, nystatin has to make direct contact. This is why doctors instruct you to swish the suspension around your mouth for as long as possible before swallowing. Rushing through that step and gulping it down means the medication spends seconds rather than minutes on the infected surfaces, and the results suffer accordingly.
Solid dosage forms like pastilles and lozenges dissolve slowly, which extends the time the drug stays in contact with oral tissue. Research on pastille formulations has shown that slow-dissolving forms allow patients to control how long the medication stays in their mouth, and volunteers have rated the palatability of well-designed pastilles favorably.2PubMed. Nystatin and lidocaine pastilles for the local treatment of oral mucositis That extended contact time is one reason lozenges and pastilles sometimes outperform the liquid in practice, even though the active ingredient is the same.
The Standard Dosing Routine
For adults with oral thrush, the typical regimen is 4 to 6 milliliters of nystatin suspension (100,000 units per milliliter) swished in the mouth four times a day, usually after meals and at bedtime. You hold the liquid in your mouth, moving it around to coat all surfaces, for at least one to two minutes before swallowing. Treatment usually lasts about 14 days, or at least 48 hours after symptoms have cleared, to reduce the chance of relapse.
Infants receive smaller doses, often 1 to 2 milliliters applied to each side of the mouth with a dropper or swab. In newborns, nystatin has been used for decades as a first-line treatment for thrush, and its long track record in this age group is one of its strengths. For denture wearers, clinicians sometimes recommend soaking the dentures overnight in nystatin suspension in addition to applying it inside the mouth, since Candida can colonize denture surfaces and reinfect the tissue each morning.3PubMed Central. Management of Chronic Atrophic Candidiasis (Denture Stomatitis)—A Narrative Review
Nystatin Versus Fluconazole
The question many people and prescribers face is whether nystatin or fluconazole is the better choice for oral thrush. For straightforward cases in otherwise healthy people, the two are reasonably close. A trial comparing fluconazole (50 mg per day for 7 days) against nystatin suspension (rinsed four times daily for 21 days) found that about 87% of fluconazole patients and 80% of nystatin patients showed cure or major improvement after treatment. Symptom relief was similarly comparable. Relapse rates trended higher in the nystatin group, but the differences did not reach statistical significance.4PubMed. Fluconazole versus nystatin in the treatment of oral candidosis
The picture changes in immunocompromised patients. A Cochrane review pooling data from 14 trials and over 1,500 patients found that nystatin performed no better than placebo at preventing fungal colonization in severely immunosuppressed individuals. Fluconazole, by contrast, was significantly more effective than nystatin at preventing both invasive fungal infections and colonization.5Cochrane Library. Nystatin for prevention and treatment of fungal infections in severely immunodepressed patients A separate trial in leukemia patients found that fluconazole prophylaxis succeeded in about 68% of patients compared to 47% on nystatin, a statistically significant gap.6PubMed. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia
The takeaway is fairly clear: for mild, uncomplicated thrush in people with healthy immune systems, nystatin works well and is often preferred because it avoids the drug interactions and liver concerns that come with systemic antifungals. For people with significant immune suppression, such as those undergoing chemotherapy or organ transplantation, fluconazole or other systemic agents are generally the better choice. Nystatin simply cannot reach fungal organisms that have invaded deeper tissue, because it never leaves the gut lumen.
Nystatin Versus Miconazole in Infants
For baby thrush specifically, the comparison with miconazole oral gel is worth knowing about. A multicenter randomized trial in otherwise healthy infants found dramatically different cure rates: by day 8, miconazole gel had cleared the infection in about 97% of infants, while nystatin suspension managed only about 38%. Even by day 12, nystatin reached only about 54% clinical cure.7PubMed. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension An earlier, smaller trial found miconazole gel achieved 100% cure versus 75% for nystatin, though the gel caused more minor stomach upset and was less well-accepted by patients.8PubMed. Prospective comparison of miconazole gel and nystatin suspension in the treatment of oral candidiasis
Despite these numbers, nystatin remains widely used for infant thrush in many countries, partly because of its long safety record and partly because miconazole oral gel is not available everywhere. In the United States, for example, miconazole oral gel is not FDA-approved for infants, so nystatin is typically the default prescription. If your pediatrician prescribes nystatin and the thrush clears slowly, these comparative results are useful context for a conversation about alternatives.
The Sugar Problem in Nystatin Suspension
One of the most underappreciated issues with nystatin oral suspension is its sugar content. According to the product label, nystatin suspension contains 50% weight-per-volume sucrose, which works out to about 2.5 grams of sugar in every 5-milliliter dose. When you swish this around your mouth four times a day for two weeks or more, you are bathing your teeth in a sugar solution ten times daily (assuming 5 mL doses four times a day, that is 10 grams of sugar lingering in the oral environment each day on top of normal dietary sugar).9The Journal of the American Dental Association. Sugar content, cariogenicity, and dental concerns with commonly used medications
This creates a real paradox. You are treating a fungal infection by deliberately holding a sugar-laden liquid against your teeth and gums, which creates ideal conditions for tooth decay. The people most likely to need prolonged or repeated courses of nystatin, such as those with dry mouth from medications, people undergoing radiation therapy, or denture wearers, are already at elevated risk for cavities. Dentists have flagged this as a genuine clinical concern.
If you are prescribed nystatin suspension and are worried about dental effects, a few practical steps help. Rinsing your mouth with plain water after the nystatin has had its contact time can wash away residual sugar. Using a sugar-free formulation, if one is available in your area, sidesteps the issue entirely. Lozenges and pastilles, though they also need to be checked for sugar content, sometimes use sugar substitutes. And simply being aware of the issue means you can discuss it with your dentist, who may recommend additional fluoride protection during your treatment course.
Denture Stomatitis
Denture stomatitis is chronic inflammation and redness under a denture, almost always caused by Candida colonizing both the oral tissue and the denture surface. It is remarkably common, affecting a large proportion of denture wearers, and is one of the conditions where nystatin has been studied most extensively.
A systematic review and meta-analysis of nystatin in oral candidiasis found that nystatin suspension can be considered a first-choice treatment for denture stomatitis, performing comparably to photodynamic therapy sessions.10PubMed Central. Nystatin Effectiveness in Oral Candidiasis Treatment: A Systematic Review & Meta-Analysis of Clinical Trials A separate clinical trial comparing nystatin to an herbal extract (Zataria multiflora) found that both significantly reduced Candida colony counts and tissue redness after 14 days, with no significant difference between them.11PubMed Central. Comparison of Antifungal Efficacy of Zataria Multiflora and Nystatin for Treatment of Denture Stomatitis: A Randomized Clinical Trial
The challenge with denture stomatitis is that the infection almost always comes back if the denture itself is not decontaminated. Candida forms a sticky biofilm on acrylic denture surfaces, and treating only the mouth while ignoring the denture is like mopping the floor while the faucet is still running. Soaking dentures in nystatin suspension overnight is one strategy, but thorough daily cleaning of the denture and removing it at night are equally important parts of the solution.
Nystatin’s Spectrum Against Different Candida Species
Most oral candidiasis is caused by Candida albicans, and nystatin handles that species well. But non-albicans species like C. glabrata, C. krusei, C. tropicalis, and C. parapsilosis are increasingly recognized as causes of oral and systemic infections, particularly in patients who have had repeated antifungal exposure.
Lab studies show that nystatin does have activity against these non-albicans species, though the duration of its post-exposure antifungal effect varies considerably. The lingering growth suppression after exposure was shortest for C. albicans (about 7 hours) and longest for C. parapsilosis (about 15 hours), with others falling in between.12PubMed. The in vitro post-antifungal effect of nystatin on Candida species of oral origin These lab results are interesting but translating them directly to clinical outcomes is tricky. A study of vaginal candidiasis, not oral, but informative for understanding the drug’s spectrum, found that nystatin’s cure rate dropped sharply for non-albicans species (about 44%) compared to C. albicans, while fluconazole maintained high efficacy across species.13PubMed. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species
For practical purposes, if you have a Candida infection that is not responding to nystatin, one possibility your clinician may consider is that a non-albicans species is involved. Culture and sensitivity testing can identify the organism and guide a switch to a more effective agent.
Safety, Side Effects, and Special Populations
Nystatin’s safety profile is one of its biggest selling points. Because it passes through the digestive tract without being absorbed, it does not burden the liver or kidneys and has essentially no systemic side effects. The most common complaints are mild nausea, stomach upset, and a taste that many patients describe as unpleasant. Some people experience diarrhea, particularly at higher doses.
Allergic reactions are rare but possible, as with any medication. If you notice swelling of the face, lips, or tongue, or develop a rash or difficulty breathing after using nystatin, that warrants immediate medical attention.
Nystatin is generally considered safe during pregnancy and breastfeeding, given its lack of systemic absorption. It is one of the few antifungals that prescribers feel comfortable using in the first trimester, when many other drugs are avoided. For the same reason, it is the default choice for neonatal thrush, with decades of use in newborns. A trial in low-birth-weight neonates found that oral nystatin combined with probiotics reduced Candida colonization in stool samples by the seventh day of life and was associated with shorter hospital stays and faster feeding milestones compared to probiotics alone.14PubMed Central. Randomized controlled clinical trial of the impact of combined application of rhamnosus probiotics and oral nystatin on the colonization of intestinal Candida albicans in low birth weight neonates <2,500 grams
The drug’s affordability is another practical advantage. As a decades-old, off-patent medication, nystatin is significantly cheaper than newer antifungals.15PubMed Central. Yeasts in the Gut: From Commensals to Infectious Agents For patients who need a short course for uncomplicated thrush, cost can be a meaningful factor.
Effects on the Broader Oral Microbiome
An interesting question is whether nystatin, by targeting Candida, also affects other organisms in the mouth. A small study of healthy adults who used nystatin oral rinse found that half the participants were free of salivary C. albicans after treatment, and no Candida isolates showed resistance to nystatin. The study also found a significant reduction in Streptococcus mutans, the main bacterium responsible for tooth decay, at three-month follow-up.16PubMed Central. Effects of Nystatin oral rinse on oral Candida species and Streptococcus mutans among healthy adults That finding is provocative because it suggests nystatin might disrupt cooperative relationships between Candida and cavity-causing bacteria, though whether this translates into any meaningful cavity prevention is far from established.
Resistance to nystatin remains uncommon, which is remarkable for a drug that has been in continuous clinical use since the 1950s. The mechanism of action, physically disrupting the fungal membrane rather than interfering with a single enzyme, makes it harder for organisms to evolve resistance through simple genetic mutations. That said, some Candida species with altered membrane composition, such as certain strains of C. glabrata, can show reduced susceptibility.
Newer Formulations on the Horizon
The classic nystatin suspension has well-known drawbacks: the taste is bad, the sugar content is high, the contact time depends on patient compliance, and the four-times-daily schedule is easy to forget. Researchers have been working on improved delivery systems designed to address all of these issues, including mucoadhesive tablets that stick to the oral mucosa for prolonged drug release, nanoemulsions that improve how the drug interacts with fungal biofilms, and reformulated lozenges with better flavor profiles.17Instalab. Nystatin Oral: Why the Lozenge Beats the Liquid
Mucoadhesive tablets are perhaps the most promising near-term improvement. By adhering to the inner cheek or gum, they release nystatin slowly over hours rather than the minute or two you can realistically hold a liquid in your mouth. This approach directly addresses the contact-time limitation that is at the root of many treatment failures. Some of these formulations have reached clinical use in parts of Europe, though they remain less widely available than the standard suspension globally.
There has also been interest in combining nystatin with other agents. A pastille formulation pairing nystatin with lidocaine, for example, was developed for patients with oral mucositis, the painful mouth sores that often accompany chemotherapy. The lidocaine provides pain relief while the nystatin addresses the fungal overgrowth that commonly complicates mucositis, and the pastille format keeps both drugs in the mouth longer than a rinse would.18PubMed. Nystatin and lidocaine pastilles for the local treatment of oral mucositis For patients dealing with both pain and infection in their mouths, a single dosage form that handles both is a practical improvement over juggling separate medications.
When Nystatin Is Not Enough
Nystatin is a workhorse for mild-to-moderate mucosal candidiasis, but there are situations where it falls short. Invasive candidiasis, where the organism has entered the bloodstream or deeper organs, cannot be treated with a drug that stays in the gut. Patients with esophageal candidiasis, common in untreated HIV infection, generally need systemic antifungals because the infection extends beyond what a topical agent can reach. And as the Cochrane review showed, severely immunocompromised patients are better served by systemic prophylaxis than by nystatin alone.19Cochrane Library. Nystatin for prevention and treatment of fungal infections in severely immunodepressed patients
Recurrent thrush that keeps coming back despite proper nystatin use is another signal to reassess. Persistent or frequently recurring oral candidiasis can be an early sign of an underlying immune issue, uncontrolled diabetes, or a medication side effect (inhaled steroids are a common culprit). If you find yourself needing nystatin more than two or three times a year, the question to ask is not “do I need a stronger antifungal?” but rather “why does this keep happening?” Identifying and addressing the root cause, whether that means adjusting a steroid inhaler technique, improving blood sugar control, or getting tested for immune deficiencies, is more productive than cycling through progressively stronger antifungal courses.